Chromium's Hidden Role in Insulin Resistance, Metabolic Syndrome, and Diabetes

Main Article Content

Fatimah Kadhim Ibrahim Al- Mahdawi
Mazin Razooqi Mohammed
Mustafa Ghani Taher
Mudher MB. Alsunbuli
Ammar Kadi
Irina Potoroko

Abstract

In this study, we developed a spectrophotometric method to explore the association of nutrient composition, particularly of chromium, and insulin resistance. Forty volunteers were used for tissue concentrations by using the Oligo-Check spectrophotometer to determine chromium, zinc, and selenium measurements. Subjects were divided into low chromium (n=18) and normal chromium level (n=22) groups. Serum insulin and fasting blood glucose were determined by Roche Cobas systems, and HOMA-IR was calculated according to the formula. Findings showed that insulin resistance was significantly higher in the low chromium group, concluding that; "depleted chromium leads to insulin resistance., The implications of the study emphasize the need of watchfulness and regulation of chromium in patients with insulin resistance.


Bullet points:



  • Spectrophotometric Analysis: Chromium, zinc, and selenium levels were measured in 40 volunteers using the Oligo-Check spectrophotometer.

  • Group Comparison: Participants were divided into low-chromium (n = 18) and normal-chromium (n = 22) groups; insulin and fasting glucose were analyzed using Roche Cobas systems.

  • Key Finding: The low-chromium group showed significantly higher HOMA-IR values, indicating that reduced chromium levels contribute to insulin resistance.

Article Details

How to Cite
[1]
F. K. I. Al- Mahdawi, M. R. Mohammed, M. G. Taher, M. M. Alsunbuli, A. Kadi, and I. Potoroko, “Chromium’s Hidden Role in Insulin Resistance, Metabolic Syndrome, and Diabetes”, SHIFAA, vol. 2025, pp. 76–81, Dec. 2025, doi: 10.70470/SHIFAA/2025/010.
Section
Articles